Abstract:For many biopharmaceuticals, subcutaneous (sc) administration is the only viable route. However, there is no in vitro method available accurately predicting the absorption profiles of subcutaneously injected pharmaceuticals. In this work, we show that a recently developed microfluidics method for interaction studies (MIS) has the potential to be useful in this respect. The method utilises the responsiveness of polyelectrolyte microgel networks to oppositely charged molecules as a means to monitor the interaction between peptides and hyaluronic acid (HA), a major constituent of the subcutaneous extracellular matrix. We use the method to determine parameters describing the strength of interaction between peptide and HA as well as the peptide's aggregation tendency and transport properties in HA networks. The results from MIS studies of the peptide drugs exenatide, pramlintide, vancomycin, polymyxin B, lanreotide, MEDI7219 and AZD2820 are compared with results from measurements with the commercially available SCISSOR system and in vivo absorption and bioavailability data from the literature. We show that both MIS and SCISSOR reveal differences in the peptides' diffusivity and tendency to aggregate in the presence of HA. We show that MIS is particularly good at discriminating between peptides forming aggregates stabilised by non-electrostatic forces in the presence of HA, and peptides forming complexes stabilised by electrostatic interactions with HA. The method provides two parameters that can be used to quantify the peptides' aggregation tendency, the one describing the peptide packing density in complexes with HA and the other the apparent diffusivity upon release in a medium of physiological ionic strength and pH. The order of the peptides when ranked by increasing binding strength at pH 7.4 determined with MIS is shown to be in agreement with the order when ranked by the apparent 1st order absorption rate constant ( k a ) after sc administration in humans: lanreotide (Autogel) < exenatide (IRF) < AZD2820 < pramlintide < lanreotide (IRF) (IRF: Immediate release formulation). A correlation is found between the 1st order release rate constant determined with SCISSOR and k a for lanreotide (Autogel), exenatide and AZD2820. A mechanism relating the magnitude of k a to the peptides' charge is proposed.

Stabilization and Transdermal Delivery of an Investigational Peptide Using MicroCor® Solid-State Dissolving Microstructure Arrays

Coated microneedles for transdermal delivery of a potent pharmaceutical peptide

Optimisation of a Microfluidic Method for the Delivery of a Small Peptide

Development and Evaluation of a Water-Free In Situ Depot Gel Formulation for Long-Acting and Stable Delivery of Peptide Drug ACTY116

Thermal stability of exenatide encapsulated in stratified dissolving microneedles during storage

A microfluidic in vitro method predicting the fate of peptide drugs after subcutaneous administration

Dissolvable microneedle arrays for intradermal delivery of biologics: fabrication and application

Therapeutic Peptides and Proteins: Stabilization Challenges and Biomedical Applications by Means of Nanodelivery Systems

Systemic delivery of proteins using novel peptides via the sublingual route

Metal-organic Frameworks As Protective Matrices for Peptide Therapeutics.

A High-Efficiency, Low-Toxicity, Phospholipids-Based Phase Separation Gel for Long-Term Delivery of Peptides.

Oral Bioavailability Enhancement of Melanin Concentrating Hormone, Development and In Vitro Pharmaceutical Assessment of Novel Delivery Systems

Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches

Immobilized Thermolysin for Highly Efficient Production of Low-Molecular-weight Protamine--an Attractive Cell-Penetrating Peptide for Macromolecular Drug Delivery Applications.

Strategies for Improving Peptide Stability and Delivery

Biocompatible Ionic Liquid Self-Assembled Transdermal Delivery System (P-M IL/AKE) for Significantly Improved Skin Photoaging and Reduced Wrinkles

Fabrication of Poly Lactic- co-Glycolic Acid Microneedles for Sustained Delivery of Lipophilic Peptide-Carfilzomib

Noninvasive and Efficient Peptide Delivery by a Novel Biocompatible Ionic Liquid

Assessing Physicochemical Stability of Monoclonal Antibodies in a Simulated Subcutaneous Environment

Sustained-release multiparticulates for oral delivery of a novel peptidic ghrelin agonist: Formulation design and in vitro characterization

Crystalline Antibody‐Laden Alginate Particles: A Platform for Enabling High Concentration Subcutaneous Delivery of Antibodies